LRP6 and Alzheimer disease: Thirdly, apolipoprotein E4 (ApoE4), the most important risk factor for late-onset AD [103, 104], can inhibit Wnt/β-catenin signaling in neuronal LRP6-expressing PC-12 cells [105].